We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Procter & Gamble
PG
$335B
| $152M | 0.58% |
908,312
+52,725
| +6% | +$8.98M |
|
|
27
Abbott
ABT
$192B
| $152M | 0.58% |
1,344,134
-348,420
| -21% | -$40.3M |
|
28
TSMC
TSM
$2.23T
| $147M | 0.56% |
743,000
+111,000
| +18% | +$21.5M |
|
29
Home Depot
HD
$342B
| $143M | 0.55% |
368,236
+22,720
| +7% | +$9.28M |
|
30
Dynatrace
DT
$14.3B
| $142M | 0.54% |
2,611,400
+292,400
| +13% | +$15.9M |
|
31
Core & Main
CNM
$8.62B
| $141M | 0.54% |
2,771,614
-213,915
| -7% | -$10.1M |
|
32
Service Corp International
SCI
$11.5B
| $135M | 0.52% |
1,695,748
-114,400
| -6% | -$9.36M |
|
33
Intuitive Surgical
ISRG
$142B
| $133M | 0.51% |
255,743
+63,201
| +33% | +$32.9M |
|
34
Amazon
AMZN
$2.88T
| $132M | 0.5% |
600,200
+79,000
| +15% | +$16.2M |
|
35
Clean Harbors
CLH
$16.7B
| $129M | 0.49% |
560,873
-9,953
| -2% | -$2.47M |
|
36
Oracle
ORCL
$442B
| $121M | 0.46% |
726,118
+176,575
| +32% | +$31.4M |
|
|
37
Vertex Pharmaceuticals
VRTX
$133B
| $119M | 0.46% |
296,036
-115,479
| -28% | -$53.5M |
|
38
Salesforce
CRM
$158B
| $119M | 0.45% |
355,126
+22,671
| +7% | +$7.24M |
|
39
Bank of America
BAC
$453B
| $118M | 0.45% |
2,686,184
+271,571
| +11% | +$11.9M |
|
40
Tyler Technologies
TYL
$13B
| $115M | 0.44% |
199,051
+56,900
| +40% | +$34.4M |
|
41
Amgen
AMGN
$225B
| $114M | 0.44% |
438,803
-1,545
| -0.4% | -$458K |
|
42
Quanta Services
PWR
$102B
| $111M | 0.42% |
351,949
-4,067
| -1% | -$1.31M |
|
|
43
Synopsys
SNPS
$79B
| $111M | 0.42% |
229,134
+108,716
| +90% | +$56.8M |
|
44
Verra Mobility
VRRM
$714M
| $102M | 0.39% |
4,215,800
+200,000
| +5% | +$4.95M |
|
45
Coca-Cola
KO
$373B
| $102M | 0.39% |
1,632,128
+112,180
| +7% | +$7.32M |
|
46
Graphic Packaging
GPK
$3.46B
| $102M | 0.39% |
3,738,152
-455,400
| -11% | -$13.2M |
|
47
Itron
ITRI
$4.49B
| $97.6M | 0.37% |
899,289
-500
| -0.1% | -$55.9K |
|
|
48
EXL Service
EXLS
$5.2B
| $97.4M | 0.37% |
2,194,690
+1,664,400
| +314% | +$72M |
|
49
AptarGroup
ATR
$8.47B
| $94.1M | 0.36% |
598,830
+60,000
| +11% | +$10M |
|
50
Nasdaq
NDAQ
$53.5B
| $92.7M | 0.35% |
1,199,696
+148,970
| +14% | +$11.5M |
|
Similar funds
VIA
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.